|
Livzon Pharmaceutical Group Inc. is a pharmaceutical company engaged in the research, development, production, and marketing of chemical drugs, biological products, traditional Chinese medicine preparations, active pharmaceutical ingredients (APIs), and diagnostic reagents. The company's product portfolio focuses on therapeutic areas including gastroenterology, neuropsychiatry, and gonadotropin-releasing hormone (GnRH) agonists for assisted reproduction and oncology. Key products include Leuprorelin Microspheres, Triptorelin Acetate Microspheres, and the IL-17A/F inhibitor Lecankitug. The company also manufactures APIs and intermediates and offers diagnostic reagents and equipment. Livzon serves markets in China and internationally, with a strategic focus on internationalization and global innovation. The company is a subsidiary of Joincare Pharmaceutical Industry Group Co., Ltd. and operates through subsidiaries such as Livzon MABPharm, Zhuhai Livzon Diagnostics, and Sichuan Guangda Pharmaceutical. Summarised from the company's own disclosures, fiscal year ended Mar 2026 |
Industry Drug Manufacturers - General | Homepage livzon.com.cn |
| Sector Healthcare | IR page livzon.com.cn/Investor | |
|
Tags
chemical drugs, biological products, traditional chinese medicine, active pharmaceutical ingredients, diagnostic reagents, gastroenterology, neuropsychiatry, gonadotropin-releasing hormone, assisted reproduction, oncology, vaccines, antibiotics, Leuprorelin Microspheres for Injection, Triptorelin Acetate Microspheres for Injection, Lecankitug Injection, Ilaprazole Enteric-Coated Tablets, Ilaprazole Sodium for Injection, Aripiprazole Microspheres for Injection, Brexpiprazole Microspheres, Semaglutide Injection, Tocilizumab, Livzon MABPharm, Zhuhai Livzon Diagnostics, Sichuan Guangda Pharmaceutical, Joincare Pharmaceutical Industry Group, Livzon Hecheng, Jiaozuo Hecheng, Xinbeijiang Pharma, Fuzhou Fuxing, Ningxia Pharma, Livzon Pharmaceutical Factory, Shanghai Livzon, Jiaozuo Joincare, Haibin Pharma, Lanbao Pharma, Sanmed Gene, Livzon Hong Kong, Shengmei Bio, Livzon Cayman, Livzon HK, Livzon Bio, Begol
|
Press page livzon.com.cn/news_list |
Metrics
| Valuation | |
|---|---|
| Market cap | HK$ 7.39B |
| Market cap (USD) | $ 941.793M |
| P/E | 9.67 |
| PEG | — |
| P/BV | — |
| P/S | 0.71 |
| P/OCF | 4.95 |
| P/FCF | — |
| Dividend yield | 17.3% |
| Turnover / mcap | 0.50% |
| Returns | |
|---|---|
| ROE | — |
| ROI | — |
| ROIC | — |
| Profit margin | — |
| Growth | |
|---|---|
| Revenue growing | Yes |
| Profits growing | No |
| Revenue up 3y | Yes |
| Revenue up 5y | Yes |
| Earnings growth 3y (net profit CAGR) | -21.6% |
| Quality | |
|---|---|
| Profitable | Yes |
| Margin expanding | No |
| Buying back stock | — |
| Diluting (TTM) | — |
| Debt/Equity | — |
| Podcast bulls (TTM) | Sign up |
| Podcast bears (TTM) | Sign up |
| Podcast sentiment (TTM) | Sign up |
| Podcast sentiment % (TTM) | Sign up |
| News sentiment (TTM) | 0 |
| Quality score | 30.0% |
| Insiders | |
|---|---|
| Buys, 1w | Sign up |
| Buys, 1m | Sign up |
| Buys, 1y | Sign up |
| Sells, 1w | Sign up |
| Sells, 1m | Sign up |
| Sells, 1y | Sign up |
Sign up to see this company's insider trades
Sign up to see institutional holdings
Sign UpPodcast Mentions
Sign up to see podcast mentions and sentiment
Sign UpAnnouncements and reports published on HKEXnews, newest first, monthly and next-day returns, proxy forms and board-meeting notices included. The link opens the announcement on HKEXnews. Press releases from the company's own website, newest first.
Prompts
Click prompts to add them under the company line, click again to take one out, then copy the result into your AI chat. Shared by Asian Century Stocks and Uncovered Thai Stocks. Thank you.
ETFs Holding Livzon Pharmaceutical Group Inc.
Exchange-traded funds whose newest published daily portfolio holds one of the company's listings, largest weight first.